![Wolfgang Renner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wolfgang Renner
President chez Alpha Anomeric SAS
Profil
Wolfgang A.
Renner is the founder of Cytos Biotechnology AG, which was founded in 1995.
He held the title of Chief Executive Officer & Head-Media Relations in 2011.
Currently, he is the President & Director of Alpha Anomeric SAS and a Member of both the Swiss Federation of Commerce & Industry and the Swiss National Science Foundation.
Dr. Renner received a doctorate degree from the Swiss Federal Institute of Technology in 1995.
Postes actifs de Wolfgang Renner
Sociétés | Poste | Début |
---|---|---|
Swiss Federation of Commerce & Industry | Corporate Officer/Principal | 13/05/2010 |
Swiss National Science Foundation | Corporate Officer/Principal | 13/05/2010 |
Alpha Anomeric SAS
![]() Alpha Anomeric SAS Pharmaceuticals: MajorHealth Technology Alpha Anomeric SAS Develops genetic medicines for severe neuromuscular diseases. The company is headquartered in Paris, France. | President | - |
Anciens postes connus de Wolfgang Renner
Sociétés | Poste | Fin |
---|---|---|
Cytos Biotechnology AG
![]() Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Fondateur | 01/08/2011 |
Formation de Wolfgang Renner
Swiss Federal Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
Cytos Biotechnology AG
![]() Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Commercial Services |
Swiss Federation of Commerce & Industry | |
Swiss National Science Foundation | |
Alpha Anomeric SAS
![]() Alpha Anomeric SAS Pharmaceuticals: MajorHealth Technology Alpha Anomeric SAS Develops genetic medicines for severe neuromuscular diseases. The company is headquartered in Paris, France. | Health Technology |